跳至主要内容
临床试验/ISRCTN31514446
ISRCTN31514446已完成不适用

The NCRI adjuvant breast cancer (ABC) trial

Institute of Cancer Research (UK)0 个研究点目标入组 6,000 人开始时间: 2000年4月6日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
6,000

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
Female

入选标准

  • All women with early invasive breast cancer requiring adjuvant systemic therapy are eligible for the trial providing they have:
  • 1. Early (operable) breast cancer
  • 2. Histological confirmation of invasive carcinoma
  • 3. No previous malignancy (except carcinoma in situ [CIS] cervix or basal cell carcinoma)
  • 4. Received no previous systemic treatment for their disease
  • 5. Given consent and available for subsequent follow-up

排除标准

  • Not provided at time of registration

研究者

发起方
Institute of Cancer Research (UK)

相似试验

已完成
不适用
Cancer Research Campaign adjuvant breast trial for patients over the age of 50BreastCancer
ISRCTN29547753Cancer Research UK (CRUK) (UK)
招募中
2 期
Pre-operative phase II trial for breast cancer with nivolumab in combination with novel IO (BELLINI trial)breast cancer
NL-OMON54814ederlands Kanker Instituut90
进行中(未招募)
1 期
Pre-operative study for breast cancer with nivolumab in combination with other therapyMedDRA version: 21.1Level: LLTClassification code 10006188Term: Breast cancer female NOSSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 20.0Level: LLTClassification code 10006194Term: Breast cancer NOS stage ISystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 20.0Level: LLTClassification code 10006195Term: Breast cancer NOS stage IISystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 20.0Level: LLTClassification code 10006196Term: Breast cancer NOS stage IIISystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)
EUCTR2018-004188-30-NLKI-AV90
已完成
3 期
Adjuvant Chemotherapy Trial of S-1 for breast cancer with ER-positive and HER2-negative.Breast cancer
JPRN-UMIN000003969Department of Breast Surgery, Graduate School of Medicine, Kyoto University1,930
撤回
不适用
A randomised controlled trial of breast cancer patients treated with chemotherapy in a hospital day unit or at home; an analysis of cost and patient reported outcomesCancer - BreastPublic Health - Health service researchBreast cancer
ACTRN12615000197538A/Prof Suzanne Robinson130